Related references
Note: Only part of the references are listed.The Current Status of Psychedelics in Psychiatry
David Nutt et al.
JAMA PSYCHIATRY (2021)
Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives
David J. Cox et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2021)
The entropic tongue: Disorganization of natural language under LSD
Camila Sanz et al.
CONSCIOUSNESS AND COGNITION (2021)
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing
Carla Agurto et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings
Matthias Forstmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials
Juan Jose Fuentes et al.
FRONTIERS IN PSYCHIATRY (2020)
MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn't
Louise Morgan
ANNALS OF GENERAL PSYCHIATRY (2020)
Sustained Improvement of Negative Self-Schema After a Single Ketamine Infusion: An Open-Label Study
Gregor Hasler et al.
FRONTIERS IN NEUROSCIENCE (2020)
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Joost J. Breeksema et al.
CNS DRUGS (2020)
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
Jonathan Hamill et al.
CURRENT NEUROPHARMACOLOGY (2019)
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
Survey of subjective God encounter experiences: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT
Roland R. Griffiths et al.
PLOS ONE (2019)
Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports
Charlotte Martial et al.
CONSCIOUSNESS AND COGNITION (2019)
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
Facundo Carrillo et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Psychedelics and the essential importance of context
Robin L. Carhart-Harris et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Unifying Theories of Psychedelic Drug Effects
Link R. Swanson
FRONTIERS IN PHARMACOLOGY (2018)
Facebook language predicts depression in medical records
Johannes C. Eichstaedt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The Varieties of the Psychedelic Experience: A Preliminary Study o f the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines
Federico Zamberlan et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2018)
Dimensions of consciousness and the psychedelic state
Tim Bayne et al.
NEUROSCIENCE OF CONSCIOUSNESS (2018)
Linguistic analysis of patients with mood and anxiety disorders during cognitive behavioral therapy
Anke R. Sonnenschein et al.
COGNITIVE BEHAVIOUR THERAPY (2018)
Alterations of consciousness and mystical-type experiences after acute LSD in humans
Matthias E. Liechti et al.
PSYCHOPHARMACOLOGY (2017)
Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
Francesco Bartoli et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Effects of 3,4-Methylenedioxymethamphetamine on Patient Utterances in a Psychotherapeutic Setting
Vicka Rael Corey et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2016)
Effects of ketamine on cognition-emotion interaction in the brain
Milan Scheidegger et al.
NEUROIMAGE (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
The paradoxical psychological effects of lysergic acid diethylamide (LSD)
R. L. Carhart-Harris et al.
PSYCHOLOGICAL MEDICINE (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
Intimate insight: MDMA changes how people talk about significant others
Matthew J. Baggott et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Ketamine and other glutamate receptor modulators for depression in adults
Caroline Caddy et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
A Window into the Intoxicated Mind? Speech as an Index of Psychoactive Drug Effects
Gillinder Bedi et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing
Matthew G. Kirkpatrick et al.
NEUROPSYCHOPHARMACOLOGY (2014)
When Small Words Foretell Academic Success: The Case of College Admissions Essays
James W. Pennebaker et al.
PLOS ONE (2014)
MDMA alters emotional processing and facilitates positive social interaction
Margaret C. Wardle et al.
PSYCHOPHARMACOLOGY (2014)
Antidepressant-like effects of ecstasy in subjects with a predisposition to depression
Irina Majumder et al.
ADDICTIVE BEHAVIORS (2012)
Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study
Jose Carlos Bouso et al.
PLOS ONE (2012)
Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner
Michael Lyvers et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2012)
Measuring effect size: a robust heteroscedastic approach for two or more groups
Rand R. Wilcox et al.
JOURNAL OF APPLIED STATISTICS (2011)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
Erich Studerus et al.
PLOS ONE (2010)
Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech
Gina F. Marrone et al.
PSYCHOPHARMACOLOGY (2010)
The Psychological Meaning of Words: LIWC and Computerized Text Analysis Methods
Yla R. Tausczik et al.
JOURNAL OF LANGUAGE AND SOCIAL PSYCHOLOGY (2010)
Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys
Louisa Degenhardt et al.
PLOS MEDICINE (2008)
Gender differences in language use: An analysis of 14,000 text samples
Matthew L. Newman et al.
DISCOURSE PROCESSES (2008)
Psychological effects of ketamine in healthy volunteers - Phenomenological study
E. Pomarol-Clotet et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
F Hasler et al.
PSYCHOPHARMACOLOGY (2004)
Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers
CJA Morgan et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Linguistic predictors of trauma pathology and physical health
J Alvarez-Conrad et al.
APPLIED COGNITIVE PSYCHOLOGY (2001)
Share Paper
